Pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed that an group analyst meeting is scheduled on 14th February 2025 via Digital.
The above information is a part of company’s filings submitted to BSE.